Global Rheumatology Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatology Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Disease Modifying Anti-rheumatic Drugs
1.2.3 Nonsteroidal Anti-inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Uric Acid Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Rheumatology Drugs Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Rheumatology Drugs Market Size (2017-2028)
2.2 Rheumatology Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Rheumatology Drugs Market Size by Region (2017-2022)
2.4 Global Rheumatology Drugs Market Size Forecast by Region (2023-2028)
2.5 Global Top Rheumatology Drugs Countries Ranking by Market Size
3 Rheumatology Drugs Competitive by Company
3.1 Global Rheumatology Drugs Revenue by Players
3.1.1 Global Rheumatology Drugs Revenue by Players (2017-2022)
3.1.2 Global Rheumatology Drugs Market Share by Players (2017-2022)
3.2 Global Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Rheumatology Drugs Revenue
3.4 Global Rheumatology Drugs Market Concentration Ratio
3.4.1 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Drugs Revenue in 2021
3.5 Global Rheumatology Drugs Key Players Head office and Area Served
3.6 Key Players Rheumatology Drugs Product Solution and Service
3.7 Date of Enter into Rheumatology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Rheumatology Drugs Breakdown Data by Type
4.1 Global Rheumatology Drugs Historic Revenue by Type (2017-2022)
4.2 Global Rheumatology Drugs Forecasted Revenue by Type (2023-2028)
5 Global Rheumatology Drugs Breakdown Data by Application
5.1 Global Rheumatology Drugs Historic Market Size by Application (2017-2022)
5.2 Global Rheumatology Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rheumatology Drugs Revenue by Company (2020-2022)
6.2 North America Rheumatology Drugs Revenue by Type (2017-2028)
6.3 North America Rheumatology Drugs Revenue by Application (2017-2028)
6.4 North America Rheumatology Drugs Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Rheumatology Drugs Revenue by Company (2020-2022)
7.2 Europe Rheumatology Drugs Revenue by Type (2017-2028)
7.3 Europe Rheumatology Drugs Revenue by Application (2017-2028)
7.4 Europe Rheumatology Drugs Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Rheumatology Drugs Revenue by Company (2020-2022)
8.2 Asia Pacific Rheumatology Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Rheumatology Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Rheumatology Drugs Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Rheumatology Drugs Revenue by Company (2020-2022)
9.2 Latin America Rheumatology Drugs Revenue by Type (2017-2028)
9.3 Latin America Rheumatology Drugs Revenue by Application (2017-2028)
9.4 Latin America Rheumatology Drugs Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rheumatology Drugs Revenue by Company (2020-2022)
10.2 Middle East and Africa Rheumatology Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Rheumatology Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Rheumatology Drugs Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Details
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Rheumatology Drugs Products and Services
11.1.4 Takeda Pharmaceutical Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.1.5 Takeda Pharmaceutical Rheumatology Drugs SWOT Analysis
11.1.6 Takeda Pharmaceutical Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Rheumatology Drugs Products and Services
11.2.4 Sanofi Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.2.5 Sanofi Rheumatology Drugs SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Genentech
11.3.1 Genentech Company Details
11.3.2 Genentech Business Overview
11.3.3 Genentech Rheumatology Drugs Products and Services
11.3.4 Genentech Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.3.5 Genentech Rheumatology Drugs SWOT Analysis
11.3.6 Genentech Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Rheumatology Drugs Products and Services
11.4.4 Novartis Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.4.5 Novartis Rheumatology Drugs SWOT Analysis
11.4.6 Novartis Recent Developments
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Details
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Rheumatology Drugs Products and Services
11.5.4 Janssen Biotech Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.5.5 Janssen Biotech Rheumatology Drugs SWOT Analysis
11.5.6 Janssen Biotech Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Rheumatology Drugs Products and Services
11.6.4 Amgen Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.6.5 Amgen Rheumatology Drugs SWOT Analysis
11.6.6 Amgen Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Rheumatology Drugs Products and Services
11.7.4 AbbVie Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.7.5 AbbVie Rheumatology Drugs SWOT Analysis
11.7.6 AbbVie Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Rheumatology Drugs Products and Services
11.8.4 Pfizer Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.8.5 Pfizer Rheumatology Drugs SWOT Analysis
11.8.6 Pfizer Recent Developments
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Details
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Products and Services
11.9.4 Bristol-Myers Squibb Company Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.9.5 Bristol-Myers Squibb Company Rheumatology Drugs SWOT Analysis
11.9.6 Bristol-Myers Squibb Company Recent Developments
11.10 Merck & Co.
11.10.1 Merck & Co. Company Details
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Rheumatology Drugs Products and Services
11.10.4 Merck & Co. Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022)
11.10.5 Merck & Co. Rheumatology Drugs SWOT Analysis
11.10.6 Merck & Co. Recent Developments
12 Rheumatology Drugs Market Dynamics
12.1 Rheumatology Drugs Market Trends
12.2 Rheumatology Drugs Market Drivers
12.3 Rheumatology Drugs Market Challenges
12.4 Rheumatology Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Rheumatology Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Disease Modifying Anti-rheumatic Drugs
Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Uric Acid Drugs
Table 6. Key Players of Others
Table 7. Global Rheumatology Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Rheumatology Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Rheumatology Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Rheumatology Drugs Revenue Market Share by Region (2017-2022)
Table 11. Global Rheumatology Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Rheumatology Drugs Market Share by Players (2017-2022)
Table 13. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2021)
Table 14. Ranking of Global Top Rheumatology Drugs Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Rheumatology Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Rheumatology Drugs Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Rheumatology Drugs Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Rheumatology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Rheumatology Drugs Revenue Market Share by Type (2017-2022)
Table 22. Global Rheumatology Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Rheumatology Drugs Revenue Market Share by Type (2023-2028)
Table 24. Global Rheumatology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Rheumatology Drugs Revenue Market Share by Application (2017-2022)
Table 26. Global Rheumatology Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Rheumatology Drugs Revenue Market Share by Application (2023-2028)
Table 28. North America Rheumatology Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Rheumatology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Rheumatology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Rheumatology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Rheumatology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Rheumatology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Rheumatology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Rheumatology Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Rheumatology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Rheumatology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Rheumatology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Rheumatology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Rheumatology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Rheumatology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Rheumatology Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Rheumatology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Rheumatology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Rheumatology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Rheumatology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Rheumatology Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Rheumatology Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Rheumatology Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Rheumatology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Rheumatology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Rheumatology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Rheumatology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Rheumatology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Rheumatology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Rheumatology Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Rheumatology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Rheumatology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Rheumatology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Rheumatology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Rheumatology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Rheumatology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 63. Takeda Pharmaceutical Company Details
Table 64. Takeda Pharmaceutical Business Overview
Table 65. Takeda Pharmaceutical Rheumatology Drugs Product and Services
Table 66. Takeda Pharmaceutical Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 67. Takeda Pharmaceutical Rheumatology Drugs SWOT Analysis
Table 68. Takeda Pharmaceutical Recent Developments
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Rheumatology Drugs Product and Services
Table 72. Sanofi Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 73. Sanofi Rheumatology Drugs SWOT Analysis
Table 74. Sanofi Recent Developments
Table 75. Genentech Company Details
Table 76. Genentech Business Overview
Table 77. Genentech Rheumatology Drugs Product and Services
Table 78. Genentech Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 79. Genentech Rheumatology Drugs SWOT Analysis
Table 80. Genentech Recent Developments
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Rheumatology Drugs Product and Services
Table 84. Novartis Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 85. Novartis Rheumatology Drugs SWOT Analysis
Table 86. Novartis Recent Developments
Table 87. Janssen Biotech Company Details
Table 88. Janssen Biotech Business Overview
Table 89. Janssen Biotech Rheumatology Drugs Product and Services
Table 90. Janssen Biotech Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 91. Janssen Biotech Rheumatology Drugs SWOT Analysis
Table 92. Janssen Biotech Recent Developments
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Rheumatology Drugs Product and Services
Table 96. Amgen Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 97. Amgen Rheumatology Drugs SWOT Analysis
Table 98. Amgen Recent Developments
Table 99. AbbVie Company Details
Table 100. AbbVie Business Overview
Table 101. AbbVie Rheumatology Drugs Product and Services
Table 102. AbbVie Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 103. AbbVie Rheumatology Drugs SWOT Analysis
Table 104. AbbVie Recent Developments
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Rheumatology Drugs Product and Services
Table 108. Pfizer Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 109. Pfizer Rheumatology Drugs SWOT Analysis
Table 110. Pfizer Recent Developments
Table 111. Bristol-Myers Squibb Company Company Details
Table 112. Bristol-Myers Squibb Company Business Overview
Table 113. Bristol-Myers Squibb Company Rheumatology Drugs Product and Services
Table 114. Bristol-Myers Squibb Company Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 115. Bristol-Myers Squibb Company Rheumatology Drugs SWOT Analysis
Table 116. Bristol-Myers Squibb Company Recent Developments
Table 117. Merck & Co. Company Details
Table 118. Merck & Co. Business Overview
Table 119. Merck & Co. Rheumatology Drugs Product and Services
Table 120. Merck & Co. Rheumatology Drugs Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 121. Merck & Co. Rheumatology Drugs SWOT Analysis
Table 122. Merck & Co. Recent Developments
Table 123. Rheumatology Drugs Market Trends
Table 124. Rheumatology Drugs Market Drivers
Table 125. Rheumatology Drugs Market Challenges
Table 126. Rheumatology Drugs Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Rheumatology Drugs Sales Market Share by Type: 2021 VS 2028
Figure 2. Disease Modifying Anti-rheumatic Drugs Features
Figure 3. Nonsteroidal Anti-inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Uric Acid Drugs Features
Figure 6. Others Features
Figure 7. Global Rheumatology Drugs Sales Market Share by Application: 2021 VS 2028
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Rheumatology Drugs Report Years Considered
Figure 12. Global Rheumatology Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Rheumatology Drugs Market Size 2017-2028 (US$ Million)
Figure 14. Global Rheumatology Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Rheumatology Drugs Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Rheumatology Drugs Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Rheumatology Drugs Market Share by Players in 2021
Figure 18. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Rheumatology Drugs Revenue in 2021
Figure 20. North America Rheumatology Drugs Revenue Market Share by Company in 2021
Figure 21. North America Rheumatology Drugs Revenue Market Share by Type (2017-2028)
Figure 22. North America Rheumatology Drugs Revenue Market Share by Application (2017-2028)
Figure 23. North America Rheumatology Drugs Revenue Share by Country (2017-2028)
Figure 24. U.S. Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Rheumatology Drugs Revenue Market Share by Company in 2021
Figure 27. Europe Rheumatology Drugs Revenue Market Share by Type (2017-2028)
Figure 28. Europe Rheumatology Drugs Revenue Market Share by Application (2017-2028)
Figure 29. Europe Rheumatology Drugs Revenue Share by Country (2017-2028)
Figure 30. Germany Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 31. France Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Rheumatology Drugs Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Rheumatology Drugs Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Rheumatology Drugs Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Rheumatology Drugs Revenue Share by Region (2017-2028)
Figure 39. China Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. India Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Taiwan Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Philippines Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Vietnam Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Latin America Rheumatology Drugs Revenue Market Share by Company in 2021
Figure 51. Latin America Rheumatology Drugs Revenue Market Share by Type (2017-2028)
Figure 52. Latin America Rheumatology Drugs Revenue Market Share by Application (2017-2028)
Figure 53. Latin America Rheumatology Drugs Revenue Share by Country (2017-2028)
Figure 54. Mexico Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Brazil Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Argentina Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Middle East and Africa Rheumatology Drugs Revenue Market Share by Company in 2021
Figure 58. Middle East and Africa Rheumatology Drugs Revenue Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Rheumatology Drugs Revenue Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Rheumatology Drugs Revenue Share by Country (2017-2028)
Figure 61. Turkey Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Saudi Arabia Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. UAE Rheumatology Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 65. Sanofi Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 66. Genentech Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 67. Novartis Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 68. Janssen Biotech Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 69. Amgen Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 70. AbbVie Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 71. Pfizer Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 72. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 73. Merck & Co. Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed